Switzerland· 68862006
Vafseo 450 mg, Filmtabletten
A vadadustat product containing vadadustatum, registered in Switzerland by Salmon Pharma GmbH and dispensed under Swissmedic category A. The same ATC class is registered in 13 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Vadadustat is registered in 13 of 19 countries.
Countries holding a registration under ATC B03XA08 (vadadustat), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 8 of them publish a price we can compare per daily dose
Vadadustat · ATC B03XA08
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vadadustat costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- Switzerland: $15.64 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Vadadustat · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$15.64
The record
At a glance
Swissmedic (Switzerland)- Active substance
- vadadustatum
- Manufacturer
- Salmon Pharma GmbH
- Country
- Switzerland (CH)
- ATC code
- B03XA08
- ATC class
- Vadadustat
- Defined daily dose
- 0.3 g, O
- Swissmedic category
- A
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vadadustat in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVAFSEOMedice Arzneimittel Pütter GmbH & Co. KG, Iserlohn
- FinlandVafseoMedice Arzneimittel Pütter GmbH & Co. KG
- IrelandVAFSEO 450 mg Film-coated tabletMedice Arzneimittel Putter GmbH & Co. K.G
- IcelandVafseoMedice Arzneimittel Pütter GmbH & Co KG
- NetherlandsVafseo 450 mg filmomhulde tablettenMedice Arzneimittel Pütter GmbH & Co. KG
- PolandVafseoMedice Arzneimittel Puetter GmbH & Co. KG
- SwedenVafseo 450 mg Filmdragerad tablettMedice Arzneimittel Pütter GmbH & Co. KG
- BelgiumVafseo 450 mgAkebia Europe
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Vafseo
- Norway · Vafseo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3c240edd-a79d-4225-a525-0b8817242ac5 GET /v1/drugs/3c240edd-a79d-4225-a525-0b8817242ac5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about vadadustat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.